Clinical Cancer Drugs

Clinical Cancer Drugs

ISSN: 2212-697X
E-ISSN: 2212-6988

Clinical Cancer Drugs publishes original research, expert reviews, and thematic issues covering all core areas of translational and clinical cancer drug research.
The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and pharmacologist.
Clinical Cancer Drugs is an international, peer-reviewed journal on all aspects of cancer drugs published continuously (print & online) by Bentham Science Publishers.

Coverage	2014
Language	English
Journal Status	Active

Latest Articles Latest articles RSS feed

- Understanding Immunomodulation and Managing Cancer Cachexia: A Narrative Review
  
  Authors: Lingbing Zhang and Xun Zhu
- Durvalumab in Oncology: Pioneering Advances through Recent Clinical Trials and Expanding Therapeutic Horizons
  
  Authors: Afzal Hussain and Ashfaq Hussain
- Exosomes in Oncology: Advancing Gene Therapy and Targeted Drug Delivery Systems
  
  Authors: Harmanjot Kaur, Md. Moidul Islam, Jyotibikash Kalita, Abhishek Chauhan, Hiya Kamal Das and Akashdeep Singh
- CAR-T Cell Therapy: A Revolutionary Approach to Targeting and Treating Cancer
  
  Authors: Virender Kumar, Davinder Kumar, Monika Verma, Hardik Pruthi, Tanya Dhiman, Naveen Khatri, Vandana Garg, Saloni Kakkar and Ashwani Kumar
- Targeting Cancer with Graphene Quantum Dots (GQDs): A Novel Approach
  
  Authors: Md. Moidul Islam, Jyotibikash Kalita, Simranjeet Kaur and Akashdeep Singh
- Harnessing the Potential of Metallic Nanoparticles for Modulating the Tumor Microenvironment and Immune Responses in Breast Cancer Immunotherapy
  
  Authors: Shatrudhan Prajapati and Shikha Yadav
- Advancements in Cancer Therapeutics: Emerging Agents and Combination Strategies in Drug Discovery
  
  Authors: Afzal Hussain and Ashfaq Hussain
- Solid Lipid Nanoparticles: Preparation Methods and Therapeutic Potential in Oral Cancer
  
  Authors: Md Moidul Islam, Sushil Kumar Sinmgh, Jyotibikash Kalita and Manish Kumar
- An Unexpected Cutaneous Response to a Skin Test to Paclitaxel: A Case Report
  
  Authors: Lucía González-Bravo, José Barbarroja-Escudero, María José Sánchez-González, Ana Laiseca-Anton, Dorotea Matas-Dominguez, Josefa Monjo-Paz, Ileana María Medina-Expósito, Ana Belen Piteiro and Melchor Alvarez-Mon
- Repositioning Proton Pump Inhibitors: Expanding Applications from Acid Suppression to Cancer Therapeutics
  
  Authors: Erica Alves, Gurupadayya Bannimath and Prabitha Prabhakaran
More Less

Most Cited Most Cited RSS feed

- Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies
  
  Authors: Benny Johnson and Daruka Mahadevan
- Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
  
  Authors: Horacio Gonzalez, Carolina Lema, Robert A. Kirken, Rosa A. Maldonado, Armando Varela- Ramirez and Renato J. Aguilera
- Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
  
  Authors: Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter
- Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells
  
  Authors: Yahaira Santiago-Vázquez, Umashankar Das, Armando Varela-Ramirez, Sarah T. Baca, Yoshira Ayala-Marin, Carolina Lema, Swagatika Das, Alaa Baryyan, Jonathan R. Dimmock and Renato J. Aguilera
- Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients
  
  Authors: Manon Launay, Joseph Ciccolini, Claire Fournel, Carmello Blanquicett, Charlotte Dupuis, Nicolas Fakhry, Florence Duffaud, Sebastien Salas and Bruno Lacarelle
- Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors
  
  Authors: G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken
- New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia
  
  By Tadeusz Robak
- Inhibition of ERN1 Signaling is Important for the Suppression of Tumor Growth
  
  Authors: Oleksandr H. Minchenko, Dariia O. Tsymbal, Olena O. Khita and Dmytro O. Minchenko
- Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer
  
  Authors: Manikanta Swamy Murahari and Mayur C. Yergeri
- Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors
  
  Authors: Atasi De Chatterjee, Debarshi Roy, Priscilla Guevara, Rituraj Pal, Mahesh Narayan, Sukla Roychowdhury and Siddhartha Das
More Less

Clinical Cancer Drugs

Latest Articles Latest articles RSS feed

Most Read This Month

Most Cited Most Cited RSS feed